CLINICAL_TRIALS
trial_result
· 2016-09-01
Clinical Trial Update: BAX 326 Pediatric Study [Phase 2, Phase 3]
Summary
Clinical trial update for BAX 326 in pediatric patients completed phases 2 and 3 with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baxalta now part of Shire | Conditions: Hemophilia B | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-09-01